Pharmacovigilance Risk Assessment Committee

临床试验

Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)

计划入组 800,000 人 · 首次发布于 2024 年 5 月 10 日

已完成

RPCEC00000231

Pharmacovigilance-VALERGEN-Asthma

计划入组 2,108 人

已完成

NCT01853839

Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk Patients

计划入组 1,674 人 · 首次发布于 2013 年 5 月 15 日

药物

查看全部 68 →

Small Molecule

Approved

Tetrofosmin

相关疾病：Breast Cancer, Hypoperfusion，另有 1 项

C₁₈H₄₀O₄P₂

Small Molecule

Approved

Tamoxifen(Soltamox)

生产企业：Rosemont group ltd, Astrazeneca pharmaceuticals lp，另有 9 家

相关疾病：Breast Cancer, Contralateral Breast Cancer，另有 7 项

C₂₆H₂₉NO · Rx

Small Molecule

Approved

Raloxifene(Evista, Optruma, Raloxifene Teva)

生产企业：Eli lilly and co

相关疾病：Invasive Breast Cancer, Osteoporosis，另有 1 项

C₂₈H₂₇NO₄S · Rx

机构

查看全部 42 →

INTERNATIONAL RESCUE COMMITTEE, U.K.

United Kingdom

ADVANTAGE RISK MANAGEMENT CO., LTD.

Japan

PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE

United States

资讯

查看全部 14367 →

去年

EMA Investigates Potential Link Between Semaglutide and Rare Eye Condition NAION

5个月前

EMA Issues Urgent Safety Alert for Cenobamate Following Severe Liver Injury Reports

去年

临床试验

Pharmacovigilance Assessment of Reporting of Cardiovascular Adverse Events With Antineoplastic Agents (PARCA)

Pharmacovigilance-VALERGEN-Asthma

Impact of Ramadan on Achieving Joint National Committee (JNC) 7 Treatment Goals in CV Risk Patients

药物

Tetrofosmin

Tamoxifen(Soltamox)

Raloxifene(Evista, Optruma, Raloxifene Teva)

机构

INTERNATIONAL RESCUE COMMITTEE, U.K.

ADVANTAGE RISK MANAGEMENT CO., LTD.

PHYSICIANS COMMITTEE FOR RESPONSIBLE MEDICINE

资讯

EMA Investigates Potential Link Between Semaglutide and Rare Eye Condition NAION

EMA Issues Urgent Safety Alert for Cenobamate Following Severe Liver Injury Reports

Clinuvel Seeks EMA Approval for Increased SCENESSE Dosage in Europe